185 related articles for article (PubMed ID: 3127691)
1. H-ras activation in benign and self-regressing skin tumors (keratoacanthomas) in both humans and an animal model system.
Leon J; Kamino H; Steinberg JJ; Pellicer A
Mol Cell Biol; 1988 Feb; 8(2):786-93. PubMed ID: 3127691
[TBL] [Abstract][Full Text] [Related]
2. Oncogene involvement in tumor regression: H-ras activation in the rabbit keratoacanthoma model.
Corominas M; Leon J; Kamino H; Cruz-Alvarez M; Novick SC; Pellicer A
Oncogene; 1991 Apr; 6(4):645-51. PubMed ID: 1840681
[TBL] [Abstract][Full Text] [Related]
3. Differential expression of the H-ras mutated and normal alleles in rabbit DMBA-induced keratoacanthomas.
Matesanz F; Oliva MR; Villamarin A; Kamino H; Pellicer A
Int J Cancer; 1995 May; 61(5):679-82. PubMed ID: 7539411
[TBL] [Abstract][Full Text] [Related]
4. Oncogene activation in human benign tumors of the skin (keratoacanthomas): is HRAS involved in differentiation as well as proliferation?
Corominas M; Kamino H; Leon J; Pellicer A
Proc Natl Acad Sci U S A; 1989 Aug; 86(16):6372-6. PubMed ID: 2668964
[TBL] [Abstract][Full Text] [Related]
5. ras activation in human tumors and in animal model systems.
Corominas M; Sloan SR; Leon J; Kamino H; Newcomb EW; Pellicer A
Environ Health Perspect; 1991 Jun; 93():19-25. PubMed ID: 1773791
[TBL] [Abstract][Full Text] [Related]
6. Co-operation between follicular ornithine decarboxylase and v-Ha-ras induces spontaneous papillomas and malignant conversion in transgenic skin.
Smith MK; Trempus CS; Gilmour SK
Carcinogenesis; 1998 Aug; 19(8):1409-15. PubMed ID: 9744537
[TBL] [Abstract][Full Text] [Related]
7. Activation of protooncogenes in spontaneously occurring non-liver tumors from C57BL/6 x C3H F1 mice.
Candrian U; You M; Goodrow T; Maronpot RR; Reynolds SH; Anderson MW
Cancer Res; 1991 Feb; 51(4):1148-53. PubMed ID: 1997158
[TBL] [Abstract][Full Text] [Related]
8. 7,12-Dimethylbenz[a]anthracene-induced mouse keratinocyte malignant transformation independent of Harvey ras activation.
Schneider BL; Bowden GT; Sutter C; Schweizer J; Han KA; Kulesz-Martin MF
J Invest Dermatol; 1993 Oct; 101(4):595-9. PubMed ID: 8409529
[TBL] [Abstract][Full Text] [Related]
9. Activated Ki-ras genes in bladder epithelial cell lines transformed by treatment of primary mouse bladder explant cultures with 7,12-dimethylbenz[a]anthracene.
Brookes P; Cooper CS; Ellis MV; Warren W; Gardner E; Summerhayes IC
Mol Carcinog; 1988; 1(2):82-8. PubMed ID: 3151261
[TBL] [Abstract][Full Text] [Related]
10. Mutations in ras oncogenes: rare events in ultraviolet B radiation-induced mouse skin tumorigenesis.
Khan SG; Mohan RR; Katiyar SK; Wood GS; Bickers DR; Mukhtar H; Agarwal R
Mol Carcinog; 1996 Feb; 15(2):96-103. PubMed ID: 8599584
[TBL] [Abstract][Full Text] [Related]
11. Activation of K-ras by codon 13 mutations in C57BL/6 X C3H F1 mouse tumors induced by exposure to 1,3-butadiene.
Goodrow T; Reynolds S; Maronpot R; Anderson M
Cancer Res; 1990 Aug; 50(15):4818-23. PubMed ID: 2196119
[TBL] [Abstract][Full Text] [Related]
12. Mutagenesis of the Ha-ras oncogene in mouse skin tumors induced by polycyclic aromatic hydrocarbons.
Bizub D; Wood AW; Skalka AM
Proc Natl Acad Sci U S A; 1986 Aug; 83(16):6048-52. PubMed ID: 3016738
[TBL] [Abstract][Full Text] [Related]
13. Activation of H-ras oncogenes in preneoplastic mouse mammary tissues.
Kumar R; Medina D; Sukumar S
Oncogene; 1990 Aug; 5(8):1271-7. PubMed ID: 2118247
[TBL] [Abstract][Full Text] [Related]
14. Characterization of a transforming N-ras gene in the human hepatoma cell line Hep G2: additional evidence for the importance of c-myc and ras cooperation in hepatocarcinogenesis.
Richards CA; Short SA; Thorgeirsson SS; Huber BE
Cancer Res; 1990 Mar; 50(5):1521-7. PubMed ID: 2154325
[TBL] [Abstract][Full Text] [Related]
15. Oncogene alterations in in vitro transformed rat tracheal epithelial cells.
Mass MJ; Schorschinsky NS; Lasley JA; Beeman DK; Austin SJ
Mutat Res; 1990 Apr; 243(4):291-8. PubMed ID: 1691445
[TBL] [Abstract][Full Text] [Related]
16. ras gene activation in rat tumors induced by benzidine congeners and derived dyes.
Reynolds SH; Patterson RM; Mennear JH; Maronpot RR; Anderson MW
Cancer Res; 1990 Jan; 50(2):266-72. PubMed ID: 2403837
[TBL] [Abstract][Full Text] [Related]
17. Low incidence of c-Ha-ras gene mutations in benign and malignant cutaneous lesions from transplant recipients.
Pélisson I; Chardonnet Y; Euvrard S; Schmitt D
Int J Cancer; 1993 Dec; 55(6):915-20. PubMed ID: 8253528
[TBL] [Abstract][Full Text] [Related]
18. Development of keratoacanthomas and squamous cell carcinomas in transgenic rabbits with targeted expression of EJras oncogene in epidermis.
Peng X; Griffith JW; Han R; Lang CM; Kreider JW
Am J Pathol; 1999 Jul; 155(1):315-24. PubMed ID: 10393863
[TBL] [Abstract][Full Text] [Related]
19. Mutational activation of the cellular Harvey ras oncogene in rat esophageal papillomas induced by methylbenzylnitrosamine.
Wang Y; You M; Reynolds SH; Stoner GD; Anderson MW
Cancer Res; 1990 Mar; 50(5):1591-5. PubMed ID: 2406014
[TBL] [Abstract][Full Text] [Related]
20. [Mutational activation of H-ras and K-ras (Codon 12,61) genes in 7,12 dimethylbenz(a)anthracene induced rat ovarian tumors].
Kataoka A; Nishida T; Sugiyama T; Hirakawa N; Yakushiji M
Nihon Sanka Fujinka Gakkai Zasshi; 1993 Feb; 45(2):119-24. PubMed ID: 8429245
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
